纹理分析在结直肠癌新辅助放化疗疗效预测及预后分析中的应用及研究进展

doi:10.24920/003572

摘要/Abstract

摘要：

结直肠癌是常见的恶性肿瘤，在我国的发病率和死亡率逐步攀升。目前新辅助放化疗多用于结直肠癌患者的治疗中，有助于改善预后。但由于个体差异性，患者对新辅助放化疗的敏感性各不相同，因此预测治疗效果对下一步治疗方案的选择尤为重要。纹理分析作为一种图像后处理技术，越来越多地被应用于肿瘤影像学中。本文就纹理分析技术在结直肠癌患者新辅助放化疗疗效预测及预后分析中的应用做一综述。

关键词: 结直肠癌, 纹理分析, 新辅助放化疗, 预后

Abstract:

Colorectal cancer is one of the most common malignant tumors, and the morbidity and mortality are increasing gradually over the last years in China. Neoadjuvant chemoradiotherapy (nCRT) is currently applied to the treatment of colorectal cancer patients, and it is helpful to improve the prognosis. The sensitivity of patients to nCRT is different due to individual differences. Predicting the therapeutic effect of nCRT is of great importance for the further treatment methods. Texture analysis, as an image post-processing technique, has been more and more utilized in the field of oncologic imaging. This article reviews the application and progress of texture analysis in the therapeutic effect prediction and prognosis of nCRT for colorectal cancer.

Key words: colorectal cancer, texture analysis, neoadjuvant chemoradiotherapy, prognosis

Wang Guorong, Wang Zhiwei, Jin Zhengyu. Application and Progress of Texture Analysis in the Therapeutic Effect Prediction and Prognosis of Neoadjuvant Chemoradiotherapy for Colorectal Cancer[J].Chinese Medical Sciences Journal, 2019, 34(1): 45-50.

参考文献 41.

1.	Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6):394-424. doi: 10.3322/caac.21492. doi: 10.3322/caac.v68.6
2.	Kemeny N . The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 2010; 22(4):364-73. doi: 10.1097/CCO.0b013e32833a6c8a. doi: 10.1097/CCO.0b013e32833a6c8a
3.	Zhang S, Bai W, Tong X , et al. Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer. Oncol Lett 2019; 17(1):1062-70. doi: 10.3892/ol.2018.9682.
4.	Yang Z, Tang LH, Klimstra DS . Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol 2011; 35(6):853-60. doi: 10.1097/PAS.0b013e31821a0696. doi: 10.1097/PAS.0b013e31821a0696
5.	Tsujikawa T, Yamamoto M, Shono K , et al. Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an (18)F-FDG PET/CT texture analysis. Ann Nucl Med 2017; 31(10):752-7. doi: 10.1007/s12149-017-1208-x. doi: 10.1007/s12149-017-1208-x pmid: 28905201
6.	Kim HS, Kim JH, Yoon YC , et al. Tumor spatial heterogeneity in myxoid-containing soft tissue using texture analysis of diffusion-weighted MRI. PLoS One 2017; 12(7):e0181339. doi: 10.1371/journal.pone.0181339. doi: 10.1371/journal.pone.0181339 pmid: 28708850
7.	Van Cutsem E, Cervantes A, Adam R , et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27(8):1386-422. doi: 10.1093/annonc/mdw235. doi: 10.1093/annonc/mdw235 pmid: 27380959
8.	Li Y, Wang J, Ma X , et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Int J Biol Sci 2016; 12(8):1022-31. doi: 10.7150/ijbs.15438. doi: 10.7150/ijbs.15438 pmid: 27489505
9.	Birbeck KF, Macklin CP, Tiffin NJ , et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235(4):449-57. doi: 10.1097/00000658-200204000-00001 pmid: 11923599
10.	Rodel C, Grabenbauer GG, Papadopoulos T , et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52(2):294-303. doi: 10.1016/S0360-3016(01)02643-8 pmid: 11872273
11.	Dworak O, Keilholz L, Hoffmann A . Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12(1):19-23. doi: 10.1007/s003840050072 pmid: 9548104
12.	Davnall F, Yip CS, Ljungqvist G , et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012; 3(6):573-89. doi: 10.1007/s13244-012-0196-6. doi: 10.1007/s13244-012-0196-6 pmid: 23093486
13.	Alobaidli S , McQuaid S, South C, et al. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol 2014; 87(1042):20140369. doi: 10.1259/bjr.20140369. doi: 10.1259/bjr.20140369 pmid: 25051978
14.	Scalco E, Rizzo G . Texture analysis of medical images for radiotherapy applications. Br J Radiol 2017; 90(1070):20160642. doi: 10.1259/bjr.20160642. doi: 10.1259/bjr.20160642 pmid: 27885836
15.	Lubner MG, Smith AD, Sandrasegaran K , et al. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 2017; 37(5):1483-503. doi: 10.1148/rg.2017170056. doi: 10.1148/rg.2017170056 pmid: 28898189
16.	Habr-Gama A, Perez RO, Nadalin W , et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240(4):711-7; discussion 717-8.
17.	De Cecco CN, Ganeshan B, Ciolina M , et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol 2015; 50(4):239-45. doi: 10.1097/rli.0000000000000116. doi: 10.1097/RLI.0000000000000116 pmid: 25501017
18.	De Cecco CN, Ciolina M, Caruso D , et al. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol (NY) 2016; 41(9):1728-35. doi: 10.1007/s00261-016-0733-8. doi: 10.1007/s00261-016-0733-8 pmid: 27056748
19.	Caruso D, Zerunian M, Ciolina M , et al. Haralick’s texture features for the prediction of response to therapy in colorectal cancer: a preliminary study. La Radiol Med 2018; 123(3):161-7. doi: 10.1007/s11547-017-0833-8. doi: 10.1007/s11547-017-0833-8 pmid: 29119525
20.	Liu M, Lv H, Liu LH , et al. Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures. Int J Colorectal Dis 2017; 32(7):1009-12. doi: 10.1007/s00384-017-2835-3. doi: 10.1007/s00384-017-2835-3 pmid: 28497403
21.	Chee CG, Kim YH, Lee KH , et al. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a potential imaging biomarker for treatment response and prognosis. PLoS One 2017; 12(8):e0182883. doi: 10.1371/journal.pone.0182883. doi: 10.1371/journal.pone.0182883 pmid: 28797063
22.	Bundschuh RA, Dinges J, Neumann L , et al. Textural parameters of tumor heterogeneity in (1)(8)F-FDG PET/CT for therapy response assessment and prognosis in patients with locally advanced rectal cancer. J Nucl Med 2014; 55(6):891-7. doi: 10.2967/jnumed.113.127340. doi: 10.2967/jnumed.113.127340 pmid: 24752672
23.	Landreau P, Drouillard A, Launoy G , et al. Incidence and survival in late liver metastases of colorectal cancer. J Gastroenterol Hepatol 2015; 30(1):82-5. doi: 10.1111/jgh.12685. doi: 10.1111/jgh.12685 pmid: 25088563
24.	Chakedis J, Squires MH, Beal EW , et al. Update on current problems in colorectal liver metastasis. Current Probl Surg 2017; 54(11):554-602. doi: 10.1067/j.cpsurg.2017.10.002. doi: 10.1067/j.cpsurg.2017.10.002
25.	Chung WS, Park MS, Shin SJ , et al. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. AJR Am J Roentgenol 2012; 199(4):809-15. doi: 10.2214/ajr.11.7910. doi: 10.2214/AJR.11.7910 pmid: 22997372
26.	Rao SX, Lambregts DM, Schnerr RS , et al. CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United European Gastroenterol J 2016; 4(2):257-63. doi: 10.1177/2050640615601603. doi: 10.1177/2050640615601603 pmid: 4804371
27.	Ahn SJ, Kim JH, Park SJ , et al. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 2016; 85(10):1867-74. doi: 10.1016/j.ejrad.2016.08.014. doi: 10.1016/j.ejrad.2016.08.014 pmid: 27666629
28.	Beckers RCJ, Trebeschi S, Maas M , et al. CT texture analysis in colorectal liver metastases and the surrounding liver parenchyma and its potential as an imaging biomarker of disease aggressiveness, response and survival. Eur J Radiol 2018; 102:15-21. doi: 10.1016/j.ejrad.2018.02.031. doi: 10.1016/j.ejrad.2018.02.031 pmid: 29685529
29.	Liang HY, Huang YQ, Yang ZX , et al. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. European Radiol 2016; 26(7):2009-18. doi: 10.1007/s00330-015-4043-2. doi: 10.1007/s00330-015-4043-2 pmid: 26494642
30.	Zhang H, Li W, Hu F , et al. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases. Abdom Radiol (New York) 2019; 44(1):65-71. doi: 10.1007/s00261-018-1682-1. doi: 10.1007/s00261-018-1682-1
31.	Miles KA, Ganeshan B, Griffiths MR , et al. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 2009; 250(2):444-52. doi: 10.1148/radiol.2502071879. doi: 10.1148/radiol.2502071879 pmid: 19164695
32.	Ng F, Ganeshan B, Kozarski R , et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 2013; 266(1):177-84. doi: 10.1148/radiol.12120254. doi: 10.1148/radiol.12120254 pmid: 23151829
33.	Jalil O, Afaq A, Ganeshan B , et al. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis 2017; 19(4):349-62. doi: 10.1111/codi.13496. doi: 10.1111/codi.13496 pmid: 27538267
34.	Lovinfosse P, Polus M, Van Daele D , et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European J Nucl Med Mol Imaging 2018; 45(3):365-75. doi: 10.1007/s00259-017-3855-5. doi: 10.1007/s00259-017-3855-5 pmid: 29046927
35.	Chicklore S, Goh V, Siddique M , et al. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. European J Nucl Med Mol Imaging 2013; 40(1):133-40. doi: 10.1007/s00259-012-2247-0. doi: 10.1007/s00259-012-2247-0 pmid: 23064544
36.	Mackin D, Fave X, Zhang L , et al. Measuring computed tomography scanner variability of radiomics features. Invest Radiol 2015; 50(11):757-65. doi: 10.1097/rli.0000000000000180. doi: 10.1097/RLI.0000000000000180
37.	Fave X, Mackin D, Yang J , et al. Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer? Med Phys 2015; 42(12):6784-97. doi: 10.1118/1.4934826. doi: 10.1118/1.4934826 pmid: 26632036
38.	Fave X, Cook M, Frederick A , et al. Preliminary investigation into sources of uncertainty in quantitative imaging features. Comput Med Imaging Graph 2015; 44:54-61. doi: 10.1016/j.compmedimag.2015.04.006. doi: 10.1016/j.compmedimag.2015.04.006 pmid: 26004695
39.	Aerts HJ, Velazquez ER, Leijenaar RT , et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014; 5:4006. doi: 10.1038/ncomms5006. doi: 10.1038/ncomms5006 pmid: 4059926
40.	Rizzo S, Botta F, Raimondi S , et al. Radiomics: the facts and the challenges of image analysis. European Radiol Exp 2018; 2(1):36. doi: 10.1186/s41747-018-0068-z. doi: 10.1186/s41747-018-0068-z
41.	Summers RM . Texture analysis in radiology: does the emperor have no clothes? Abdom Radiol (New York) 2017; 42(2):342-5. doi: 10.1007/s00261-016-0950-1. doi: 10.1007/s00261-016-0950-1 pmid: 27770161

[1]	徐文琴, 叶静静, 陈天兵. 鉴定并验证与肺腺癌预后相关的新的miRNA-mRNA调节网络[J]. Chinese Medical Sciences Journal, 2022, 37(1): 31-43.
[2]	曹剑, 王国蓉, 王志伟, 金征宇. CT纹理分析：结直肠癌KRAS基因突变状态评估的潜在生物标志物[J]. Chinese Medical Sciences Journal, 2020, 35(4): 306-314.
[3]	李文省, 张彦丽. 用于膀胱癌预后预测的lncRNA分子标记物开发[J]. Chinese Medical Sciences Journal, 2020, 35(3): 239-247.
[4]	王站, 王旭, 王文达, 郑国洋, 郭浩, 张玉石. 术前中性粒细胞与淋巴细胞比值预测可切除泌尿系肿瘤预后的价值：系统综述和荟萃分析[J]. Chinese Medical Sciences Journal, 2020, 35(3): 262-271.
[5]	朱卫华,谢文勇,张哲栋,李澍,张大方,刘以俊,朱继业,冷希圣. 59例肝门部胆管癌切除术后并发症和生存率分析[J]. Chinese Medical Sciences Journal, 2020, 35(2): 157-169.
[6]	梁玺, 胡婧楠, 何建明. 氧化偶氮甲烷-硫酸葡聚糖硫酸钠诱导小鼠结直肠肿瘤方法的优化[J]. Chinese Medical Sciences Journal, 2019, 34(4): 281-288.
[7]	李旭, 吴蔽野, 张明珠, 申乐. 全身麻醉下剖宫产术的单中心回顾性队列研究[J]. Chinese Medical Sciences Journal, 2019, 34(4): 256-262.
[8]	陈强, 张丽伟, 黄党生, 张春红, 王秋霜, 沈东, 熊敏俊, 杨菲菲. 冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析[J]. Chinese Medical Sciences Journal, 2019, 34(3): 177-183.
[9]	王英伟, 张兴华, 王波涛, 王叶, 刘梦琦, 王海屹, 叶慧义. 体素内不相干运动成像参数的纹理分析在胰腺神经内分泌肿瘤和胰腺癌鉴别诊断中的价值[J]. Chinese Medical Sciences Journal, 2019, 34(1): 1-9.
[10]	王波涛, 刘明霞, 陈志晔. 磁共振T2加权成像纹理特征分析在脑胶质母细胞瘤与脑原发性中枢神经系统淋巴瘤鉴别诊断中的价值[J]. Chinese Medical Sciences Journal, 2019, 34(1): 10-17.
[11]	刘洪娟, 周欢粉, 宗林雄, 刘梦琦, 魏世辉, 陈志晔. 视神经炎患者视神经磁共振成像直方图分析[J]. Chinese Medical Sciences Journal, 2019, 34(1): 18-23.
[12]	徐佳, 王萱, 金征宇, 游燕, 王勤, 王士阗, 薛华丹. 钆塞酸二钠增强磁共振图像纹理分析对于评价大鼠肝纤维化的价值[J]. Chinese Medical Sciences Journal, 2019, 34(1): 24-32.
[13]	王波涛, 樊文萍, 许欢, 李丽慧, 张晓欢, 王昆, 刘梦琦, 游俊浩, 陈志晔. 磁共振扩散加权成像纹理特征分析在乳腺良恶性肿瘤鉴别中的价值[J]. Chinese Medical Sciences Journal, 2019, 34(1): 33-37.
[14]	刘永胜, 赵宇. 术中神经电生理监测在胸椎管狭窄症外科治疗中的应用进展[J]. Chinese Medical Sciences Journal, 2017, 32(4): 260-264.
[15]	陈振杰, 李航, 蔡建芳, 张鑫, 李超, 邹佩美, 李明喜, 陈丽萌, 李雪梅, 李学旺, 文煜冰. 肾小球皮质密度对随访5年的IgA肾病不良预后的预测^△[J]. Chinese Medical Sciences Journal, 2017, 32(3): 145-151.

优先出版

当期目次

过刊浏览

虚拟专题

作者中心

评阅者中心